Literature DB >> 22881219

Prevalence and predictors of drooling in 7- to 14-year-old children with cerebral palsy: a population study.

Susan M Reid1, Jennifer McCutcheon, Dinah S Reddihough, Hilary Johnson.   

Abstract

AIM: To establish a prevalence estimate for drooling and explore factors associated with drooling in a population sample of children with cerebral palsy (CP) aged 7 to 14 years living in Victoria, Australia.
METHOD: A self-report questionnaire was used to collect data on drooling from parents of children born between 1996 and 2001, and registered with the Victorian Cerebral Palsy Register.
RESULTS: A total of 385 children (231 males, 154 females; mean age 10y 9mo [SD 1y 7mo], range 8-14y) were studied. The clinical type and distribution of CP were spastic (341), ataxic (16), dyskinetic (17), hypotonic (10), and unknown (1). Distribution in Gross Motor Function Classification System (GMFCS) levels was I (103), II (98), III (52), IV (63), V (61), and unknown (8). After adjustment for topographical pattern of motor impairment and GMFCS level, 40% were reported to have experienced drooling between 4 years of age and the time of completing the questionnaire. A significantly higher prevalence of drooling was found in children with poor gross motor function and in those with more severe presentations of CP, including poor head control, difficulty with eating, and inability to sustain lip closure (p<0.001 for each). Drooling was shown to be significantly associated with both intellectual disability and epilepsy in this group of children (p<0.001 for both).
INTERPRETATION: With a prevalence of 40%, drooling is an important comorbidity in CP. It was considered severe in 15% of children. Poor oromotor function was associated with drooling and could be the target of interventions for this under-researched problem. © The Authors. Developmental Medicine & Child Neurology
© 2012 Mac Keith Press.

Entities:  

Mesh:

Year:  2012        PMID: 22881219     DOI: 10.1111/j.1469-8749.2012.04382.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  15 in total

1.  A systematic review of utility values in children with cerebral palsy.

Authors:  Utsana Tonmukayakul; Long Khanh-Dao Le; Shalika Bohingamu Mudiyanselage; Lidia Engel; Jessica Bucholc; Brendan Mulhern; Rob Carter; Cathrine Mihalopoulos
Journal:  Qual Life Res       Date:  2018-08-02       Impact factor: 4.147

2.  Assessment of orofacial dysfunction using the NOT-S method in a group of Turkish children with cerebral palsy.

Authors:  Alev Alaçam; Buket Ceylan Çalık Yılmaz; Arzu Sukran Incioğlu
Journal:  Eur Arch Paediatr Dent       Date:  2019-09-06

3.  Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.

Authors:  Eigild Møller; Søren Anker Pedersen; Pablo Gustavo Vinicoff; Allan Bardow; Joan Lykkeaa; Pia Svendsen; Merete Bakke
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

4.  An investigation of the relationship of drooling with nutrition and head control in individuals with quadriparetic cerebral palsy.

Authors:  Seda Ayaz Taş; Tamer Çankaya
Journal:  J Phys Ther Sci       Date:  2015-11-30

5.  Systematic Review of Cerebral Palsy Registries/Surveillance Groups: Relationships between Registry Characteristics and Knowledge Dissemination.

Authors:  Donna S Hurley; Theresa Sukal-Moulton; Deborah Gaebler-Spira; Kristin J Krosschell; Larissa Pavone; Akmer Mutlu; Julius Pa Dewald; Michael E Msall
Journal:  Int J Phys Med Rehabil       Date:  2015-03-23

6.  Percutaneous Salivary Gland Ablation using Ethanol in a Rat Model.

Authors:  Emma Burch; Lacey Lubeley; James Murakami
Journal:  J Oral Maxillofac Res       Date:  2017-12-31

7.  The association of drooling and health-related quality of life in children with cerebral palsy.

Authors:  Shih-Chung Chang; Chin-Kai Lin; Li-Chen Tung; Nai-Yin Chang
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-11       Impact factor: 2.570

8.  The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.

Authors:  Jeremy R Parr; Emma Weldon; Lindsay Pennington; Nick Steen; Jane Williams; Charlie Fairhurst; Anne O'Hare; Raj Lodh; Allan Colver
Journal:  Trials       Date:  2014-02-17       Impact factor: 2.279

9.  Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.

Authors:  Jeremy R Parr; Emma Todhunter; Lindsay Pennington; Deborah Stocken; Jill Cadwgan; Anne E O'Hare; Catherine Tuffrey; Jane Williams; Mike Cole; Allan F Colver
Journal:  Arch Dis Child       Date:  2017-11-30       Impact factor: 3.791

10.  Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study.

Authors:  Johanna Norderyd; Jonas Graf; Agneta Marcusson; Karolina Nilsson; Eva Sjöstrand; Gunilla Steinwall; Elinor Ärleskog; Mats Bågesund
Journal:  Int J Paediatr Dent       Date:  2015-12-27       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.